![Nicklas Westerholm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 330 238 $ in data 31/05/2026
Nicklas Westerholm is currently Chief Executive Officer at Egetis Therapeutics AB since 2017, Chairman & Chief Executive Officer at Rare Thyroid Therapeutics International AB, and Independent Director at Spago Nanomedical AB since 2019.
Former positions include Head-Investor Relations at AstraZeneca PLC from 2011 to 2013 and VP-Project & Portfolio Management at AstraZeneca AB from 1995 to 2017.
Education includes undergraduate studies at the University of Stockholm and the Royal Institute of Technology.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/05/2026 | 501.508 ( 0,11% ) | 330 238 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| EGETIS THERAPEUTICS AB | Amministratore Delegato | 16/06/2017 |
| SPAGO NANOMEDICAL AB | Direttore/Membro del Consiglio | 08/05/2019 |
Rare Thyroid Therapeutics International AB
 Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Provides thyroid therapeutics research services | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | 01/06/2017 |
| ASTRAZENECA PLC | Contatto Relazioni con gli Investitori | 08/09/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Spago Nanomedical AB
 Spago Nanomedical AB BiotechnologyHealth Technology Acts as a biotechnology company | Health Technology |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Provides thyroid therapeutics research services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
